5951 - 5960 of 8785 Results
Title
Year
- Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change2021OPENTitle: Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2853End Page: 2861Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28730Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688189Citation Count: 11
-
OPENTitle: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of RasagilineJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 325End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28838Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9019575Citation Count: 15
-
OPENTitle: Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial DesignJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 10Start Page: 1774End Page: 1785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29519Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29519Citation Count: 3
-
OPENTitle: Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic VariantsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2155End Page: 2162Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29647Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29647Citation Count: 11
-
OPENTitle: Bayesian Longitudinal Modeling of Early Stage Parkinson’s Disease Using DaTscan ImagesJournal Name: Lecture Notes in Computer SciencePublisher: Springer International PublishingVol:Issue #:Start Page: 405End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-030-20351-1_31Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10258684/pdf/nihms-1899421.pdfCitation Count: 5
-
OPENTitle: EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0Journal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: 1885End Page: 1912Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-020-04817-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-020-04817-8.pdfCitation Count: 199
-
OPENTitle: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PDJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4759End Page: 4767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10586-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10586-7.pdfCitation Count: 11
-
OPENTitle: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1785End Page: 1795Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00965-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00965-9.pdfCitation Count: 17
-
OPENTitle: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area WorkshopJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1682End Page: 1691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-023-01440-xBest OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10684834/pdf/13311_2023_Article_1440.pdfCitation Count: 15
-
OPENTitle: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 307End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00246-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00246-3.pdfCitation Count: 13